Skip to content
AlternativeMed

Genetic Testing and Polygenic Risk Scores for Longevity

What genetic tests and polygenic risk scores can and cannot say about aging and disease risk, including APOE, accuracy across ancestries, privacy law and what regulators say.

Content last updated . This page has not been medically reviewed.

What this page covers

Genetic testing is sometimes sold as a way to learn how long you will live or which age-related diseases you may face. This page explains the main kinds of tests, what the published evidence says about their accuracy and usefulness, and the privacy limits. It is information only. It does not interpret anyone's results and does not suggest ordering, skipping or acting on a test. Evidence labels used here: established (well supported), promising but limited, insufficient evidence, and marketing claim.

Three different things called "genetic testing"

TypeWhat it looks atWhat it can say
Single-gene testsOne gene with a known effectSometimes a strong signal (for example BRCA1 carriers have a 60-80% absolute risk of breast cancer [1]); for others, such as APOE, it only shifts risk
Polygenic risk scoresMany small DNA differences added togetherA relative ranking of risk compared with other people
"Longevity gene" reportsA short list of variants linked to long life in studiesNo reliable personal prediction (see genetics and longevity)

The FDA notes that direct-to-consumer tests have varying levels of evidence behind their claims, and that companies do not all test the same variants, so they can give different results for the same condition. [2]

APOE: a risk shift, not a diagnosis

The APOE gene comes in several versions. MedlinePlus Genetics explains that people who carry the e4 version inherit an increased risk of developing Alzheimer's disease, not the disease itself. [3] The US Preventive Services Task Force lists the e4 version as a reported risk factor for Alzheimer disease in white and Asian populations. [4]

In a randomized trial of 162 adults without symptoms who had a parent with Alzheimer's disease, learning one's APOE result did not cause significant short-term anxiety, depression or test-related distress on average. [5] People who were already highly distressed before testing were more likely to struggle afterward. [5] Label: established for the risk association; insufficient evidence from the sources read that knowing the result changes health outcomes.

Polygenic risk scores

A polygenic risk score adds up the effects of many small variants. The National Human Genome Research Institute explains that it can only describe relative risk, meaning how one person compares with others, and that it only shows correlations, not causes. [1] Scores will always be probabilities, not certainties. [1]

What the research shows so far:

  • A 2020 review found that clinical usefulness has yet to be established and that the ability to tell people apart in the general population is low. [6]
  • In a Chinese cohort of 41,271 people followed for an average of 13 years, people in the top fifth of a coronary artery disease score had about three times the risk of those in the bottom fifth, but adding the score to a standard clinical risk score improved prediction only modestly (1% on one measure). [7]
  • Accuracy may be best in people of European ancestry because most studies used them. [1] For other groups there may not be enough data to calculate a reliable score. [1]
  • Health professionals do not yet routinely use these scores because there are no practice guidelines. [1]

Label: promising but limited for research and for refining risk in people already under care; marketing claim when a score is presented as a prediction of lifespan.

Regulation and privacy

In general, the FDA does not review direct-to-consumer tests for non-medical, general wellness or low-risk purposes before they are offered. [2] Laws change and this is not legal advice.

In the United States, the Genetic Information Nondiscrimination Act (GINA) protects against discrimination based on genetic information in health insurance and employment. [8] It does not cover long-term care, life or disability insurance, although some states add protections. [8] Think about this before sharing results.

Who may want to be extra careful

The FDA suggests that consumers consider discussing results with a genetic counselor or a qualified health care provider to understand what a result means for their own health. [2] This matters most for anyone with a strong family history or who expects a result to be upsetting.

How to judge a genetic test claim

  • Which condition is it about, and in which ancestry group was it studied?
  • Does it give a relative ranking or a real chance over a stated time?
  • What would you do differently with the result, and has that action been shown to help?
  • Who can see the data, and is it shared or sold?

Related guides

Read Biological Age vs Chronological Age, Interpreting Test Results Without Overinterpreting and Cognitive Testing and Brain Health Screening.

Frequently asked questions

Can a genetic test tell me how long I will live?

No test read for this page does that. Genetic reports on longevity are a marketing claim, while polygenic scores describe relative risk for specific diseases with low accuracy in the general population. [6][1]

If I carry APOE e4, will I get Alzheimer's disease?

Not necessarily. The e4 version raises risk but is not the disease itself, and not everyone with Alzheimer's disease has it. [3]

Is a polygenic risk score the same as my chance of getting a disease?

No. It compares you with other people and does not give a baseline or a timeframe. [1]

Are my genetic results protected by law?

In the US, GINA covers health insurance and employment but not life, disability or long-term care insurance. [8] Other countries differ; check local rules.

Does the FDA approve all consumer genetic tests?

No. Some are reviewed and others are not, depending on purpose and risk. [2]

References
  1. National Human Genome Research Institute. Polygenic Risk Scores Read 2026-10-22.
  2. U.S. Food and Drug Administration. Direct-to-Consumer Tests Read 2026-10-22.
  3. MedlinePlus Genetics. APOE gene Read 2026-10-22.
  4. U.S. Preventive Services Task Force. Cognitive Impairment in Older Adults: Screening (2020) Read 2026-10-22.
  5. Green RC, et al. Disclosure of APOE genotype for risk of Alzheimer's disease. N Engl J Med 2009. PMID 19605829. Read 2026-10-22.
  6. Lewis CM, Vassos E. Polygenic risk scores: from research tools to clinical instruments. Genome Med 2020. PMID 32423490. Read 2026-10-22.
  7. Chinese cohort study of a coronary artery disease polygenic risk score. Eur Heart J 2022. PMID 35195259. Read 2026-10-22.
  8. National Human Genome Research Institute. Genetic Discrimination Read 2026-10-22.
Education, not medical advice. This page is for general information. It does not diagnose or treat any condition and is not a substitute for care from a qualified health professional. Natural does not automatically mean safe. Ask a clinician or pharmacist before changing your care, especially if you take medication, are pregnant or breastfeeding, or have a health condition.